Prosthetic Heart Valve Market, By Position Type (Aortic Valve, Mitral Valve, and Others), By Valve Type (Mechanical Valves, Tissue Valves, and Transcatheter Valves), By End User (Hospitals, Ambulatory Surgical Centres, Catheterization Laboratory, and Others), , By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Published In : Mar 2024

Code : CMI69

Pages :155

Formats :

Excel and PDF

Industry : Medical Devices

Market Concentration and Competitive Landscape

Prosthetic Heart Valve Market Concentration, By Players

Close-monitor your Competitor's Move, Request sample copy

Technological advancements

Technological advancements represent a key driver propelling the prosthetic heart valve market. Continuous R&D efforts are reshaping the valve replacement landscape with new materials, minimally invasive techniques and transcatheter options. Mechanical heart valves which were the standards for decades are now slowly making way for bioprosthetic or tissue valves due to their superior hemodynamic performance and patient acceptance. Engineered tissue and stent construction methods have enhanced durability of bioprostheses close to 10-15 years. Transcatheter aortic valve replacement (TAVR) procedures using catheter delivered valves have emerged as a less invasive alternative to open-heart surgeries for high-risk patient groups. TAVR systems are innovative wherein collapsed valve substitutes are delivered to the site via catheters and implanted through small incisions. Their perceived advantages over surgical valves such as quicker recovery times are increasing uptake globally. Device manufacturers are striving to develop transcatheter technologies suitable for mitral, tricuspid and pulmonary valve positions as well.

Key Players Insights